
eBook - ePub
Nanotherapeutics in Cancer Vaccination and Challenges
- 494 pages
- English
- ePUB (mobile friendly)
- Available on iOS & Android
eBook - ePub
Nanotherapeutics in Cancer Vaccination and Challenges
About this book
Nanotherapeutics in Cancer Vaccination and Challenges consolidates the current research on cancer nanomedicine and therapeutic cancer vaccination to explore the most effective and promising avenues. The book covers cancer vaccines before exploring nanotherapeutics, DNA and mRNA vaccines in cancer treatment. Finally, it considers regulatory and industrial perspectives on cancer vaccination and nanotherapeutics. This resource will be useful for pharmaceutical scientists and researchers focused on biomedical engineering, chemical engineering, vaccine development, and cancer immunotherapy, along with advanced students in these subjects.
Cancer is arguably the most complex and challenging disease known to mankind. Over the last two-decades, significant advancements have been made in new and novel concepts of cancer nanomedicines. Therapeutic cancer vaccines may be utilized to inhibit further growth of advanced cancers and/or relapsed tumors that are refractory to conventional therapies, such as surgery, radiation therapy and chemotherapy.
- Presents the progress made in cancer medicines from conventional to targeted therapy
- Covers the present state-of-the-art of cancer nanomedicines and upcoming therapeutic cancer vaccination
- Contains a focus on advanced nanomaterials that are utilized for encapsulation of nucleic acid, mRNA, DNA, siRNA
Frequently asked questions
Yes, you can cancel anytime from the Subscription tab in your account settings on the Perlego website. Your subscription will stay active until the end of your current billing period. Learn how to cancel your subscription.
At the moment all of our mobile-responsive ePub books are available to download via the app. Most of our PDFs are also available to download and we're working on making the final remaining ones downloadable now. Learn more here.
Perlego offers two plans: Essential and Complete
- Essential is ideal for learners and professionals who enjoy exploring a wide range of subjects. Access the Essential Library with 800,000+ trusted titles and best-sellers across business, personal growth, and the humanities. Includes unlimited reading time and Standard Read Aloud voice.
- Complete: Perfect for advanced learners and researchers needing full, unrestricted access. Unlock 1.4M+ books across hundreds of subjects, including academic and specialized titles. The Complete Plan also includes advanced features like Premium Read Aloud and Research Assistant.
We are an online textbook subscription service, where you can get access to an entire online library for less than the price of a single book per month. With over 1 million books across 1000+ topics, we’ve got you covered! Learn more here.
Look out for the read-aloud symbol on your next book to see if you can listen to it. The read-aloud tool reads text aloud for you, highlighting the text as it is being read. You can pause it, speed it up and slow it down. Learn more here.
Yes! You can use the Perlego app on both iOS or Android devices to read anytime, anywhere — even offline. Perfect for commutes or when you’re on the go.
Please note we cannot support devices running on iOS 13 and Android 7 or earlier. Learn more about using the app.
Please note we cannot support devices running on iOS 13 and Android 7 or earlier. Learn more about using the app.
Yes, you can access Nanotherapeutics in Cancer Vaccination and Challenges by Mahfoozur Rahman,Sarwar Beg,Waleed H Almalki,Nabil A. Alhakamy,Hani Choudhry in PDF and/or ePUB format, as well as other popular books in Medicine & Pharmaceutical, Biotechnology & Healthcare Industry. We have over one million books available in our catalogue for you to explore.
Information
Table of contents
- Nanotherapeutics in Cancer Vaccination and Challenges
- Cover
- Title Page
- Copyright
- Dedication
- Table of Contents
- List of Contributors
- Preface
- Acknowledgments
- Chapter 1 Cancer vaccines
- Chapter 2 Inorganic nanoparticulate carriers in management of cancer
- Chapter 3 Recent developments in cancer vaccines
- Chapter 4 Application of nanotechnology assisted devices in cancer treatment
- Chapter 5 Advancement in protein-based nanocarriers in targeted anticancer therapy
- Chapter 6 Elastic liposomes as transcutaneous DNA vaccine vectors
- Chapter 7 Nanotechnology-based manipulation of dendritic cells for enhanced immunotherapy strategies
- Chapter 8 Peptide-based anticancer targeted therapeutics
- Chapter 9 Polyplexes-based delivery systems for cancer vaccine delivery
- Chapter 10 Lipopolyplex-based delivery system for cancer vaccine delivery
- Chapter 11 Inorganic nanoparticulate carriers in cancer vaccination
- Chapter 12 Functional nanomaterials and nanocomposite in cancer vaccines
- Chapter 13 DNA vaccines for cancer treatment
- Chapter 14 mRNA-based nanovaccines as newer treatment modalities in cancer
- Chapter 15 Cancer immunotherapy
- Chapter 16 Product development and scale-up challenges in cancer vaccine development
- Chapter 17 Regulatory landscape in the approval of cancer vaccine
- Chapter 18 Cross-presentation-based nanovaccine for cancer immunotherapy
- Chapter 19 Immunotherapy-based cancer vaccines
- Chapter 20 Therapeutic peptides in anticancer therapy
- Chapter 21 Inorganic nanoconjugates for cancer theragnosis
- Index